Cancer cells hijack glucose, alter immune cells

Cancer Cells
Dividing Cancer Cells. Credit: University of Birmingham

When cancer cells compete with immune cells for glucose, the cancer wins. As a result, the immune T cells are not healthy and don't have the weapons to kill the cancer.

"If we have a way to manipulate the metabolic pathway, the T cells may be healthier," says senior author Weiping Zou, M.D., Ph.D., Charles B. de Nancrede Professor of Surgery, Immunology and Biology at the University of Michigan Medical School.

The finding, published in Nature Immunology, suggests a potential metabolic pathway against cancer.

"We know that if we provide glucose, the tumor uses it. One question we have is, can we make T cells resistant to glucose restriction? In our study, we define a mechanism that we can use as a model to test this," Zou says.

The researchers found that T cells that have stem cell-like properties are tied to longer survival and high tumor killing capacity in human cancer. They propose altering the cancer environmental to allow the T cells to be largely functional. This would allow the T cells to kill the cancer .

Their findings also have potential as a tool to predict ovarian cancer survival, or a marker to predict effectiveness of immune therapy including checkpoint blockade or immune vaccination. Additional clinical testing is needed.


Explore further

Research explains limits of cancer immunotherapy drugs

More information: Nature Immunology, "Cancer mediates effector T cell dysfunction by targeting microRNAs and EZH2 via glycolysis restriction," published online Nov. 2, 2015. DOI: 10.1038/ni.3313
Journal information: Nature Immunology

Citation: Cancer cells hijack glucose, alter immune cells (2015, November 2) retrieved 20 October 2019 from https://medicalxpress.com/news/2015-11-cancer-cells-hijack-glucose-immune.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
237 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more